Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950138-21-000191
Filing Date
2021-03-08
Accepted
2021-03-08 09:06:09
Documents
2
Period of Report
2021-02-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 6842
2 POWER OF ATTORNEY FOR KASSIE HARROLD harroldpoa_032021.txt EX-24 3583
  Complete submission text file 0000950138-21-000191.txt   11842
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Issuer) CIK: 0001567892 (see all company filings)

EIN.: 981088325 | Fiscal Year End: 1225
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MALLINCKRODT PHARMACEUTICALS 675 MCDONNELL BLVD. HAZELWOOD MO 63042
Business Address
Harrold Kassie (Reporting) CIK: 0001849332 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35803 | Film No.: 21720750